CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-06 | Neumann Frank Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2020-12-18 | Gagnon Robert E. Chief Financial Officer | Grant or award | +67,925 | 571,635 | ||
| 2020-12-18 | Gagnon Robert E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +203,776 | 203,776 | ||
| 2020-12-18 | Stuglik Brian M Chief Executive Officer | Grant or award | +203,776 | 994,357 | ||
| 2020-12-18 | Stuglik Brian M Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +611,328 | 611,328 | ||
| 2017-09-05 | Rowinsky Eric K Director | Purchase | +2,000 | $3.84 | $8K | 2,000 |
Page 17 of 17 · 326 trades